175 related articles for article (PubMed ID: 24878371)
1. Innovative immunization protocols using chimeric recombinant protein for the production of polyspecific loxoscelic antivenom in horses.
Figueiredo LF; Dias-Lopes C; Alvarenga LM; Mendes TM; Machado-de-Ávila RA; McCormack J; Minozzo JC; Kalapothakis E; Chávez-Olórtegui C
Toxicon; 2014 Aug; 86():59-67. PubMed ID: 24878371
[TBL] [Abstract][Full Text] [Related]
2. Anti-loxoscelic horse serum produced against a recombinant dermonecrotic protein of Brazilian Loxosceles intermedia spider neutralize lethal effects of Loxosceles laeta venom from Peru.
Duarte CG; Bonilla C; Guimarães G; Machado de Avila RA; Mendes TM; Silva W; Tintaya B; Yarleque A; Chávez-Olórtegui C
Toxicon; 2015 Jan; 93():37-40. PubMed ID: 25448393
[TBL] [Abstract][Full Text] [Related]
3. Recombinant Protein Containing B-Cell Epitopes of Different
Lima SA; Guerra-Duarte C; Costal-Oliveira F; Mendes TM; Figueiredo LFM; Oliveira D; Machado de Avila RA; Ferrer VP; Trevisan-Silva D; Veiga SS; Minozzo JC; Kalapothakis E; Chávez-Olórtegui C
Front Immunol; 2018; 9():653. PubMed ID: 29666624
[TBL] [Abstract][Full Text] [Related]
4. Synthetic peptides for in vitro evaluation of the neutralizing potency of Loxosceles antivenoms.
Ramada JS; Becker-Finco A; Minozzo JC; Felicori LF; Machado de Avila RA; Molina F; Nguyen C; de Moura J; Chávez-Olórtegui C; Alvarenga LM
Toxicon; 2013 Oct; 73():47-55. PubMed ID: 23856101
[TBL] [Abstract][Full Text] [Related]
5. A reduced immunization scheme to obtain an experimental anti-Loxosceles laeta ("violinist spider") venom.
de Roodt AR; Litwin S; Dokmetjian JC; Vidal JC
J Nat Toxins; 2002 Aug; 11(3):193-203. PubMed ID: 12182539
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and immunological characteristics of Peruvian Loxosceles laeta spider venom: neutralization of its toxic effects by anti-loxoscelic antivenoms.
Guimarães G; Dias-Lopes C; Duarte CG; Felicori L; Machado de Avila RA; Figueiredo LF; de Moura J; Faleiro BT; Barro J; Flores K; Silva W; Tintaya B; Yarleque A; Bonilla C; Kalapothakis E; Salas CE; Chávez-Olortegui C
Toxicon; 2013 Aug; 70():90-7. PubMed ID: 23648420
[TBL] [Abstract][Full Text] [Related]
7. Immunoprotection elicited in rabbit by a chimeric protein containing B-cell epitopes of Sphingomyelinases D from Loxosceles spp. spiders.
Souza NA; Dias-Lopes C; Matoso ÍHG; de Oliveira CFB; Chávez-Olortegui CD; Minozzo JC; Felicori LF
Vaccine; 2018 Nov; 36(48):7324-7330. PubMed ID: 30352745
[TBL] [Abstract][Full Text] [Related]
8. Enzymatic characterization, antigenic cross-reactivity and neutralization of dermonecrotic activity of five Loxosceles spider venoms of medical importance in the Americas.
Barbaro KC; Knysak I; Martins R; Hogan C; Winkel K
Toxicon; 2005 Mar; 45(4):489-99. PubMed ID: 15733571
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous loxoscelism caused by Loxosceles similis venom and neutralization capacity of its specific antivenom.
Chatzaki M; Horta CC; Almeida MO; Pereira NB; Mendes TM; Dias-Lopes C; Guimarães G; Moro L; Chávez-Olórtegui C; Horta MC; Kalapothakis E
Toxicon; 2012 Jul; 60(1):21-30. PubMed ID: 22465492
[TBL] [Abstract][Full Text] [Related]
10. Development and evaluation of the neutralizing capacity of horse antivenom against the Brazilian spider Loxosceles intermedia.
Braz A; Minozzo J; Abreu JC; Gubert IC; Chávez-Olórtegui C
Toxicon; 1999 Sep; 37(9):1323-8. PubMed ID: 10400292
[TBL] [Abstract][Full Text] [Related]
11. A new anti-loxoscelic serum produced against recombinant sphingomyelinase D: results of preclinical trials.
de Almeida DM; Fernandes-Pedrosa Mde F; de Andrade RM; Marcelino JR; Gondo-Higashi H; de Azevedo Ide L; Ho PL; van den Berg C; Tambourgi DV
Am J Trop Med Hyg; 2008 Sep; 79(3):463-70. PubMed ID: 18784245
[TBL] [Abstract][Full Text] [Related]
12. Generation and molecular characterization of a monoclonal antibody reactive with conserved epitope in sphingomyelinases D from Loxosceles spider venoms.
Dias-Lopes C; Felicori L; Rubrecht L; Cobo S; Molina L; Nguyen C; Galéa P; Granier C; Molina F; Chávez-Olortegui C
Vaccine; 2014 Apr; 32(18):2086-92. PubMed ID: 24565754
[TBL] [Abstract][Full Text] [Related]
13. Protection against dermonecrotic and lethal activities of Loxosceles intermedia spider venom by immunization with a fused recombinant protein.
Araujo SC; Castanheira P; Alvarenga LM; Mangili OC; Kalapothakis E; Chávez-Olórtegui C
Toxicon; 2003 Mar; 41(3):261-7. PubMed ID: 12565747
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization and epitope analysis of a recombinant dermonecrotic protein from Loxosceles intermedia spider.
Felicori L; Araujo SC; de Avila RA; Sanchez EF; Granier C; Kalapothakis E; Chávez-Olórtegui C
Toxicon; 2006 Oct; 48(5):509-19. PubMed ID: 16934304
[TBL] [Abstract][Full Text] [Related]
15. Toxicity of two North American Loxosceles (brown recluse spiders) venoms and their neutralization by antivenoms.
de Roodt AR; Estevez-Ramírez J; Litwin S; Magaña P; Olvera A; Alagón A
Clin Toxicol (Phila); 2007 Sep; 45(6):678-87. PubMed ID: 17849243
[TBL] [Abstract][Full Text] [Related]
16. Generation and characterization of a recombinant chimeric protein (rCpLi) consisting of B-cell epitopes of a dermonecrotic protein from Loxosceles intermedia spider venom.
Mendes TM; Oliveira D; Figueiredo LF; Machado-de-Avila RA; Duarte CG; Dias-Lopes C; Guimarães G; Felicori L; Minozzo JC; Chávez-Olortegui C
Vaccine; 2013 Jun; 31(25):2749-55. PubMed ID: 23664158
[TBL] [Abstract][Full Text] [Related]
17. Production of monoclonal antibodies capable of neutralizing dermonecrotic activity of Loxosceles intermedia spider venom and their use in a specific immunometric assay.
Alvarenga LM; Martins MS; Moura JF; Kalapothakis E; Oliveira JC; Mangili OC; Granier C; Chávez-Olórtegui C
Toxicon; 2003 Dec; 42(7):725-31. PubMed ID: 14757202
[TBL] [Abstract][Full Text] [Related]
18. Determination of sphingomyelinase-D activity of Loxosceles venoms in sphingomyelin/cholesterol liposomes containing horseradish peroxidase.
Gomes MT; Guimarães G; Frézard F; Kalapothakis E; Minozzo JC; Chaim OM; Veiga SS; Oliveira SC; Chávez-Olórtegui C
Toxicon; 2011 Mar; 57(4):574-9. PubMed ID: 21236288
[TBL] [Abstract][Full Text] [Related]
19. Role of IgG(T) and IgGa isotypes obtained from arachnidic antivenom to neutralize toxic activities of Loxosceles gaucho, Phoneutria nigriventer and Tityus serrulatus venoms.
Toro AF; Malta MB; Soares SL; Da Rocha GC; da Silva Lira M; De Oliveira TA; Takehara HA; Lopes-Ferreira M; Santoro ML; Guidolin R; Gondo Higashi H; Fernandes I; Barbaro KC
Toxicon; 2006 Nov; 48(6):649-61. PubMed ID: 16979205
[TBL] [Abstract][Full Text] [Related]
20. Neutralization of dermonecrotic and lethal activities and differences among 32-35 kDa toxins of medically important Loxosceles spider venoms in Brazil revealed by monoclonal antibodies.
Guilherme P; Fernandes I; Barbaro KC
Toxicon; 2001 Sep; 39(9):1333-42. PubMed ID: 11384721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
